Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Germany Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20041
20051
20061
20081
20092
20107
20115
20132
20142
20155
20161
20174
20185
20197
20206
20219
20224
20236
20243
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting17
Active, not recruiting12
Terminated11
Unknown status4
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC7
AstraZeneca6
Eli Lilly and Company6
Janssen Research & Development, LLC5
Bristol-Myers Squibb4
Photocure4
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche3
Association of Urologic Oncology (AUO)2
Astellas Pharma Global Development, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms86
Carcinoma, Transitional Cell18
Non-Muscle Invasive Bladder Neoplasms9
Lung Neoplasms8
Ovarian Neoplasms8
Esophageal Neoplasms7
Pancreatic Neoplasms7
Ureteral Neoplasms7
Urethral Neoplasms7
Breast Neoplasms6

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.